Cypress Capital’s Prothena Corp PRTA Stock Holding History

Cypress Capital’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$41	–	284
2024 Q2	$41	Buy	+2	New	+$43	﹤0.01%	388

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Cypress Capital's PRTA Position: Q3 2024 in Review

Cypress Capital sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 2 shares — an estimated $41 sold.

Cypress Capital first reported a position in PRTA in Q2 2024 and held it in 1 quarter. The position peaked at $41 in Q2 2024. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

Cypress Capital reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 2 Prothena Corp shares in Q3 2024, an estimated $41.
Cypress Capital first reported a position in Prothena Corp in Q2 2024 and held it in 1 quarter.
Cypress Capital's Prothena Corp position peaked at $41 in Q2 2024.
164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.